Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/5/2025

Duloxetine Pharmacokinetics and Mechanism

Clinical Implications

  • The noradrenergic component of duloxetine modulates stress responses, including alertness, arousal, attentiveness, and vigilance, in patients with various conditions, according to the American Academy of Child and Adolescent Psychiatry 1
  • The serotonergic component of duloxetine plays a key role in the brain's ability to modulate fear, worry, and stress, in patients with anxiety disorders, as recommended by the American Academy of Child and Adolescent Psychiatry 2

Pharmacokinetic Considerations

  • Duloxetine is a moderate inhibitor of CYP2D6, requiring caution when combining with drugs metabolized by this pathway, as cautioned by the American Academy of Child and Adolescent Psychiatry 1

REFERENCES